J-Pharma is a frontrunner in developing inhibitors of L-type amino acid transporter for treating advanced refractory cancers and autoimmune diseases. Learn more about the Yokohama-based organization in this installment of our Let’s Interview Series.
Venture Valuation (VV) interviewed President and CEO, Mr. Max Yoshitake.
Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?